You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

Depression

The PMC reviewed relevant performance measures and makes the following recommendations.

Printable version of the recommendations.
Addendum to printable version of the recommendations.

ACP does not support this measure.

ID# QPP/MIPS: 411
NQF: 0711

More Information

Depression Remission at Six Months

Adult patients age 18 years and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate remission at six months defined as a PHQ-9 score less than 5. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment. This measure additionally promotes ongoing contact between the patient and provider as patients who do not have a follow-up PHQ-9 score at six months (+/- 30 days) are also included in the denominator.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# QPP/MIPS: 325
Not NQF-endorsed

More Information

Adult Major Depressive Disorder: Coordination of Care of Patients with Specific Comorbid Conditions

Percentage of medical records of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) and a specific diagnosed comorbid condition (diabetes, coronary artery disease, ischemic stroke, intracranial hemorrhage, chronic kidney disease [stages 4 or 5], End Stage Renal Disease [ESRD] or congestive heart failure) being treated by another clinician with communication to the clinician treating the comorbid condition.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# QPP/MIPS: 009
Not NQF-endorsed

More Information

Anti-Depressant Medication Management

Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported.
a. Percentage of patients who remained on an antidepressant medication for at least 84 days (12 weeks).
b. Percentage of patients who remained on an antidepressant medication for at least 180 days (6 months).
Date Reviewed: November 19, 2017

ACP supports this measure.

ID# QPP/MIPS: 367
Not NQF-endorsed

More Information

Bipolar Disorder and Major Depression: Appraisal for Alcohol or Chemical Substance Use

Percentage of patients with depression or bipolar disorder with evidence of an initial assessment that includes an appraisal for alcohol or chemical substance use.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# PQRS 106
[Removed from PQRS Jan 2015, Previously NQF 0103]

More Information

Adult Major Depressive Disorder (MDD): Comprehensive Depression Evaluation: Diagnosis and Severity

Percentage of patients aged 18 years and older with a diagnosis or recurrent episode of major depressive disorder (MDD) with evidence that they met the DSM-IV criteria for MDD AND for whom there is an assessment of depression severity during the visit in which a new diagnosis or recurrent episode was identified.
Date Reviewed: April 27, 2015

ACP does not support this measure.

ID# QPP 107
ID# NQF 0104

More Information

Adult major Depressive Disorder (MDD): Suicide Risk Assessment

Percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of major depressive disorder (MDD) with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identfied.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# QPP 009
ID# NQF 0105

More Information

Antidepressant Medication Management

Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported.
a. Percentage of patients who remained on an antidepressant medication for at least 84 days (12 weeks).
b. Percentage of patients who remained on an antidepressant medication for at least 180 days (6 months).
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# QPP 134
ID# NQF 0418

More Information

Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan

Percentage of patients aged 12 years and older screened for clinical depression using an age appropriate standardized tool AND follow-up plan documented.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# QPP 370
ID# NQF 0710

More Information

Depression Remission at Twelve Months
Adult patients age 18 and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate remission at twelve months defined as a PHQ-9 score less than 5. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment. This measure additionally promotes ongoing contact between the patient and provider as patients who do not have a follow-up PHQ-9 score at twelve months (+/- 30 days) are also included in the denominator
Date Reviewed: November 19, 2017

 

ACP supports this measure.

ID# QPP 371
ID# NQF 0712

More Information

Depression Utilization of the PHQ-9 Tool

Patients age 18 and older with the diagnosis of major depression or dysthymia who have a Patient Health Questionnaire (PHQ-9) tool administered at least once during a 4-month period in which there was a qualifying visit.
Date Reviewed: November 19, 2017

ACP does not support this measure.

ID# NQF 1885

More Information

Depression Response at Twelve Months, Progress Towards Remission

Adult patients age 18 and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate a response to treatment at twelve months defined as a PHQ-9 score that is reduced by 50% or greater from the initial PHQ-9 score. This measure applies to both patients with newly diagnosed and existing depression identified during the defined measurement period whose current PHQ-9 score indicates a need for treatment.
Date Reviewed: November 7, 2015